Press-release for stocks related to biomidwest

Prices are updated after-hours

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -1.55% | O: -0.59% H: 0.0% C: 0.0%
results

Neogen Announces Third-Quarter 2024 Results
Published: 2024-04-09 (Crawled : 12:30) - biospace.com/
NEOG 4 | $12.375 0.53% 0.53% 2.5M

| -14.28% | O: -11.57% H: 7.29% C: 2.19%
neogen results

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
Published: 2024-03-19 (Crawled : 21:00) - biospace.com/
NKTR | News | $1.39 -2.11% -2.16% 960K

| 62.35% | O: -2.12% H: 9.21% C: 4.35%
MRNS | $1.44 0.0% 1.5M

| -84.04% | O: -0.22% H: 5.56% C: 3.33%
DMAC | $2.5 3.31% 3.2% 7.4K

| -14.04% | O: -2.11% H: 4.96% C: 1.08%
business year update therapeutics financial results

Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Published: 2024-03-01 (Crawled : 12:00) - biospace.com/
BDSX | $1.26 -1.56% -1.59% 7.1K

| -18.18% | O: 23.38% H: 1.58% C: -16.84%
business year results

AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
Published: 2024-02-02 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 2.56% | O: 3.59% H: 0.0% C: 0.0%
abbvie financial results

BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
TECH | $63.48 -0.33% -0.33% 980K

| -9.67% | O: -4.58% H: 3.5% C: 2.15%
results

Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
CAH | $103.54 0.16% -0.52% 2.1M

| -5.17% | O: -4.75% H: 1.13% C: 1.06%
health results

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Published: 2024-02-01 (Crawled : 14:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K

| -25.96% | O: -3.72% H: 9.88% C: -4.34%
first year financial

Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
Published: 2023-12-12 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 25.66% | O: -2.88% H: 0.0% C: 0.0%
LGND | $70.87 1.4% 1.38% 150K

| 13.53% | O: 0.21% H: 1.18% C: 0.43%
breast life cancer pharmaceuticals results

Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 27.68% | O: 1.61% H: 0.0% C: 0.0%
LGND | $70.87 1.4% 1.38% 150K

| 14.85% | O: 0.29% H: 1.26% C: 0.87%
publication pharmaceuticals trial results

| 20.69% | O: -0.73% H: 0.78% C: 0.35%
lung abbvie positive cancer cell topline trial results

Encision Reports Second Quarter Fiscal Year 2024 Results
Published: 2023-11-14 (Crawled : 11:00) - biospace.com/
ECIA 4 | $0.44 110.0% 11K

| Email alert Add to watchlist
year results

Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
ELMD | $16.73 2.07% 0.0% 21K